Repurposing of Inhibitors of Plasmodial Aspartate Transcarbamoylase Toward Trypanosoma Cruzi

Documenti analoghi

• Small‐Molecule Allosteric Inhibitors of Human Aspartate Transcarbamoylase Suppress Proliferation of Bone Osteosarcoma Epithelial Cells
  di: Chao Wang, et al.
  Pubblicazione: (2024)
• Balinatunfib: A Clinical Oral Small Molecule TNFα Inhibitor
  di: Alexander Dömling, et al.
  Pubblicazione: (2025)
• Synthesis and In Vitro Activity of Hypofuran B and Analogs Against Plasmodium Falciparum and Trypanosoma Cruzi
  di: Cristiane Aparecida Franco, et al.
  Pubblicazione: (2025)
• Towards Improved Peptidic α‐Ketoamide Inhibitors of the Plasmodial Subtilisin‐Like SUB1: Exploration of N‐Terminal Extensions and Cyclic Constraints
  di: Anna K. Puszko, et al.
  Pubblicazione: (2025)
• Sertraline as a Scaffold for Antitrypanosoma Cruzi Drug Development: Design of Novel Derivatives and Computational Target Screening
  di: Ali S. Mijoba, et al.
  Pubblicazione: (2025)